Harris Health System-Smith Clinic
Houston, Texas, United States
Medical center in Houston, Texas
2525 Holly Hall St, Houston, TX 77054
About Harris Health System-Smith Clinic
"Administrative offices for Harris Health System"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Baylor College of Medicine
5
Michelle S Ludwig
2
Anthony Costales, MD
1
Baylor Breast Care Center
1
Dana-Farber Cancer Institute
1
Gilead Sciences
1
Incyte Corporation
1
Mothaffar Rimawi
1
NSABP Foundation Inc
1
Pfizer
1
Tannaz Armaghany
1
Clinical Trials at Harris Health System-Smith Clinic
During the past decade, Harris Health System-Smith Clinic conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 4 clinical trials were completed, i.e. on
average, 23.5% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Neoadjuvant Carboplatin and Docetaxel in Triple Negative Breast Cancer
2015-11-01
2024-09-01
Active, not recruiting
25
Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder Cancer
2016-12-01
2023-06-01
Recruiting
15
Phase I/II Study OF Metformin in Combination With Cisplatin and Radiation in Head and Neck Squamous Cell Carcinoma
2017-01-26
2022-07-07
Completed
26
Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)
2017-01-30
2019-05-06
Terminated
883
TAA Specific Cytotoxic T Lymphocytes in Patients With Pancreatic Cancer
2018-01-18
2027-05-01
Active, not recruiting
45
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
2017-12-19
2024-06-30
Active, not recruiting
1,550
INCB050465 in Combination With Rituximab, Bendamustine and Rituximab, or Ibrutinib in Participants With Previously Treated B-Cell Lymphoma (CITADEL-112)
2018-07-02
2022-06-27
Completed
50
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Harris Health System-Smith Clinic" #1 sponsor was "Baylor College of Medicine" with 5 trials, followed by "Michelle S Ludwig" with 2 trials
sponsored, "Anthony Costales, MD" with 1 trials sponsored, "Baylor Breast Care Center" with 1 trials sponsored and "Dana-Farber Cancer Institute"
with 1 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Harris Health System-Smith Clinic"
#1 collaborator was "GlaxoSmithKline" with 2 trials as a collaborator, "Center for Cell and Gene Therapy, Baylor College of Medicine" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Harris County Hospital District" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were
collaborators in the rest 12 trials.
Clinical Trials Conditions at Harris Health System-Smith Clinic
According to Clinical.Site data, the most researched conditions in "Harris Health System-Smith Clinic" are
"Breast Cancer" (4 trials), "Triple Negative Breast Cancer" (2 trials), "B-cell Lymphoma" (1 trials), "Bladder Cancer" (1 trials) and "Breast Cancer Female" (1 trials). Many other conditions were trialed in "Harris Health System-Smith Clinic" in a lesser frequency.
Clinical Trials Intervention Types at Harris Health System-Smith Clinic
Most popular intervention types in "Harris Health System-Smith Clinic" are "Drug" (15 trials), "Biological" (2 trials), "Device" (1 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (2 trials), "Docetaxel" (2 trials), "Leucovorin" (2 trials), "Oxaliplatin" (2 trials) and "Pembrolizumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Harris Health System-Smith Clinic
The vast majority of trials in "Harris Health System-Smith Clinic" are
15 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Harris Health System-Smith Clinic
Currently, there are NaN active trials in "Harris Health System-Smith Clinic".
2 are not yet recruiting,
6 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Harris Health System-Smith Clinic,
1 suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Harris Health System-Smith Clinic, 7 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".